Transitional cell carcinoma associated with aristolochic acid nephropathy: Most common cancer in chronic hemodialysis patients in China

Chinese Medical Journal

Volumn 125, Issue 24, 2012, Pages 4460-4465

  Zhou, Li ^a   Cao, Ya Li ^a   Li, Wen Ge ^a   Fu, Fang Ting ^a   Zhang, Ling ^a   Wang, Xiang ^a   Shi, Xiao Hu ^a  

^a CHINA JAPAN FRIENDSHIP HOSPITAL   (China)

Author keywords

Aristolochic acid nephropathy; End stage renal disease; Hemodialysis; Transitional cell carcinoma; Urinary tract

Indexed keywords

ADULT; AGED; ARISTOLOCHIC ACID NEPHROPATHY; ARTICLE; BREAST CANCER; CANCER MORTALITY; CANCER SURVIVAL; CHINA; CHINESE; CLINICAL FEATURE; DIGESTIVE SYSTEM CANCER; DISEASE COURSE; FEMALE; HEMODIALYSIS; HISTOPATHOLOGY; HUMAN; KIDNEY DISEASE; KIDNEY FAILURE; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; THYROID CANCER; TRANSITIONAL CELL CARCINOMA; URINARY TRACT CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; ARISTOLOCHIC ACIDS; CARCINOMA, TRANSITIONAL CELL; CHINA; FEMALE; HUMANS; KIDNEY DISEASES; MALE; MIDDLE AGED; RENAL DIALYSIS; RETROSPECTIVE STUDIES; UROLOGIC NEOPLASMS;

EID: 84874341276     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2012.24.025     Document Type: Article

References (19)

1. Mandayam S, Shahinian VB. Are chronic dialysis patients at increased risk for cancer? J Nephrol 2008; 21: 166-174.
2. Buell JF, Gross TG, Woodle ES. Malignancy after transplantation. Transplantation 2005; 80: S254-S264. (Pubitemid 41552912)
3. Nayak-Rao S. Cancer screening in end-stage renal disease. Saudi J Kidney Dis Transpl 2009; 20: 737-740.
4. Stengel B. Chronic kidney disease and cancer: a troubling connection. J Nephrol 2010; 23: 253-262.
5. Stewart JH, Vajdic CM, Van Leeuwen MT, Amin J, Webster AC, Chapma Jr. The pattern of excess cancer in dialysis and transplantation. Nephrol Dial Transplant 2009; 24: 3225-3231.
6. Tomomasa H, Amemiya H, Iizumi T, Yazaki T, Umeda T, Chimata M, et al. Urothelial tumor in dialysis patients: report of four cases. Nippon Jinzo Gakkai Shi 1990; 32: 1139-1142.
7. Wu CF, Shee JJ, Ho DR, Chen WC, Chen CS. Different treatment strategies for end stage renal disease in patients with transitional cell carcinoma. J Urol 2004; 171: 126-129.
8. Wang Z, Chen Z, Feng M, Shi S, Hao J, Dai G Relationship between RACK1 expression and clinicopathologic information of esophageal aquamous cell carcinoma. Natl Med J China (Chin) 2011; 91: 1397-1400.
9. Debelle FD, Vanherweghem JL, Nortier JL. Aristolochic acid nephropathy: a worldwide problem. Kidney Int 2008; 74: 158-169. (Pubitemid 351915079)
10. Lord GM, Tagore R, Cook T, Gower P, Pusey CD. Nephropathy caused by Chinese herbs in the UK. Lancet 1999;354:481-482. (Pubitemid 29368929)
11. Schmeiser HH, Bieler CA, Wiessler M, van Ypersele de Strihou C, Cosyns JP. Detection of DNA adducts formed by aristolochic acid in renal tissue from patients with Chinese herbs nephropathy. Cancer Res 1996; 56: 2025-2028. (Pubitemid 26119902)
12. Arlt VM, Stiborova M, Schmeiser HH. Aristolochic acid as a probable human cancer hazard in herbal remedies: a review. Mutagenesis 2002; 17: 265-277. (Pubitemid 34814645)
13. Iseki K, Osawa A, Fukiyama K. Evidence for increased cancer deaths in chronic dialysis patients. Am J Kidney Dis 1993;22:308-311.
14. Lord GM, Cook T, Arlt VM, Schmeiser HH, William G, Pusey CD. Urothelial malignant disease and Chinese herbal nephropathy. Lancet 2001; 358: 1515-1516. (Pubitemid 33055708)
15. Nortier JL, Martinez MC, Schmeiser HH, Arlt VM, Bieler CA, Petein M, et al. Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi). New Engl J Med 2000; 342: 1686-1692. (Pubitemid 30354515)
16. Vajdic CM, McDonald SP, McCredie MR, van Leeuwen MT, Stewart JH, Law M, et al. Cancer incidence before and after kidney transplantation. JAMA 2006; 296:2823-2831. (Pubitemid 44969182)
17. Wong G, Hayen A, Chapman JR, Webster AC, Wang JJ, Mitchell P. Association of CKD and cancer risk in older people. J Am Soc Nephrol 2009; 20: 1341-1350.
18. Wu CF, Chang PL, Chen CS, Chuang CK, Weng HH, Pang ST. The outcome of patients on dialysis with upper urinary tract transitional cell carcinoma. J Urol 2006; 176: 477-481.
19. Holmang S, Johansson SL. Synchronous bilateral ureteral and renal pelvic carcinomas: incidence, etiology, treatment and outcome. Cancer 2004; 101: 741-745.